FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB1 day ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
Federal Trade Commission sues largest drug middlemen for
WEB1 day ago · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
Federal Trade Commission accuses three drug middlemen of …
WEB1 day ago · By Mirna Alsharif and Berkeley Lovelace Jr. The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices. The FTC accused the "Big ...
FTC sues pharmacy benefit managers for inflating price of insulin : …
WEB15 hours ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB1 day ago · September 20, 2024 / 3:09 PM EDT / CBS News. Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while ...
FTC sues drug middlemen for allegedly inflating insulin prices
WEB1 day ago · The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen use practices that boost their profits while “artificially ...
FTC sues insulin middlemen, saying they pocket billions while …
WEB15 hours ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...
FTC Further Expands Inquiry Into Prescription Drug Middlemen …
WEBJun 8, 2023 · As part of its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued a compulsory order to a third group purchasing organization (GPO) that negotiates drug rebates on behalf of PBMs.
FTC Deepens Inquiry into Prescription Drug Middlemen
WEBMay 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu.
FTC Accuses Drug Middlemen of Inflating Insulin Prices
WEB1 day ago · Photo: Zuma Press. The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin. The FTC on ...